Literature DB >> 15484668

Prevention and treatment of heterotopic ossification after spinal cord injury.

Kresimir Banovac1, Andrew L Sherman, Irene M Estores, Filip Banovac.   

Abstract

BACKGROUND/
OBJECTIVES: Heterotopic ossification (HO) is a frequent, irreversible complication after spinal cord injury (SCI). The objective of this article is to explain the etiology of HO; present new advances in prevention, diagnosis, and management of this complication; and provide a suggested algorithm for clinical management. ETIOLOGY: Although still hypothetical, trauma and overexpression of bone morphogenic protein(s) in traumatized soft tissue appear to play important roles as initiating factors of HO. PREVENTION: Preventive use of nonsteroidal antiinflammatory agents (NSAIDs) reduces the incidence of HO by a magnitude of 2 to 3. MANAGEMENT: Early determination of serum creatine phosphokinase may have a diagnostic value in predicting the onset and severity of HO, and an NSAID may be added to etidronate therapy in the initial inflammatory phase of HO formation until C-reactive protein levels return to normal range. Surgery is indicated in a subset of patients, and a regimen that includes radiation therapy may prevent postoperative recurrence.
CONCLUSION: Significant progress has been made in the early prevention and management of HO. Further studies are needed to elucidate the etiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15484668     DOI: 10.1080/10790268.2004.11753775

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  8 in total

1.  DEGRO practical guidelines for the radiotherapy of non-malignant disorders - Part IV: Symptomatic functional disorders.

Authors:  Gabriele Reinartz; Hans Theodor Eich; Fabian Pohl
Journal:  Strahlenther Onkol       Date:  2014-12-09       Impact factor: 3.621

Review 2.  Acute complications of spinal cord injuries.

Authors:  Ellen Merete Hagen
Journal:  World J Orthop       Date:  2015-01-18

3.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

4.  Preliminary reliability and validity of a Spinal Cord Injury Secondary Conditions Scale.

Authors:  Claire Z Kalpakjian; William M Scelza; Martin B Forchheimer; Loren L Toussaint
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

5.  Inflammatory sacroiliitis in a man with spinal cord injury.

Authors:  Iltekin Duman; Mehmet A Taskaynatan; Ahmet Ozgul; Kemal Dincer
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

6.  Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.

Authors:  Avraam Ploumis; Jayne M Donovan; Mobolaji O Olurinde; Dana M Clark; Jason C Wu; Douglas J Sohn; Kevin C O'Connor
Journal:  J Spinal Cord Med       Date:  2014-05-13       Impact factor: 1.985

Review 7.  Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship.

Authors:  Xin Sun; Zachary B Jones; Xiao-Ming Chen; Libing Zhou; Kwok-Fai So; Yi Ren
Journal:  J Neuroinflammation       Date:  2016-10-06       Impact factor: 8.322

8.  Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

Authors:  Teruyo Oishi; Akiyoshi Uezumi; Arihiko Kanaji; Naoki Yamamoto; Asami Yamaguchi; Harumoto Yamada; Kunihiro Tsuchida
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.